Sharanek Ahmad, Azzi Pamela Bachour-El, Al-Attrache Houssein, Savary Camille C, Humbert Lydie, Rainteau Dominique, Guguen-Guillouzo Christiane, Guillouzo André
Inserm UMR991, Foie, Métabolisme et Cancer, Rennes, France Université de Rennes 1, Rennes, France.
ERL Inserm U1157/UMR7203, Faculté de Medecine Pierre et Marie Curie, Site Saint Antoine, Paris, France.
Toxicol Sci. 2014 Sep;141(1):244-53. doi: 10.1093/toxsci/kfu122. Epub 2014 Jun 27.
Mechanisms involved in drug-induced cholestasis in humans remain poorly understood. Although cyclosporine A (CsA) and tacrolimus (FK506) share similar immunosuppressive properties, only CsA is known to cause dose-dependent cholestasis. Here, we have investigated the mechanisms implicated in early cholestatic effects of CsA using the differentiated human HepaRG cell line. Inhibition of efflux and uptake of taurocholate was evidenced as early as 15 min and 1 h respectively after addition of 10μM CsA; it peaked at around 2 h and was reversible. These early effects were associated with generation of oxidative stress and deregulation of cPKC pathway. At higher CsA concentrations (≥50μM) alterations of efflux and uptake activities were enhanced and became irreversible, pericanalicular F-actin microfilaments were disorganized and bile canaliculi were constricted. These changes were associated with induction of endoplasmic reticulum stress that preceded generation of oxidative stress. Concentration-dependent changes were observed on total bile acid disposition, which were characterized by an increase and a decrease in culture medium and cells, respectively, after a 24-h treatment with CsA. Accordingly, genes encoding hepatobiliary transporters and bile acid synthesis enzymes were differently deregulated depending on CsA concentration. By contrast, FK506 induced limited effects only at 25-50μM and did not alter bile canaliculi. Our data demonstrate involvement of different concentration-dependent mechanisms in CsA-induced cholestasis and point out a critical role of endoplasmic reticulum stress in the occurrence of the major cholestatic features.
人类药物性胆汁淤积的相关机制仍未完全明确。尽管环孢素A(CsA)和他克莫司(FK506)具有相似的免疫抑制特性,但只有CsA已知会引起剂量依赖性胆汁淤积。在此,我们使用分化的人HepaRG细胞系研究了CsA早期胆汁淤积作用的相关机制。添加10μM CsA后,分别早在15分钟和1小时就证实了牛磺胆酸盐外排和摄取的抑制;在约2小时达到峰值且是可逆的。这些早期效应与氧化应激的产生和cPKC途径的失调有关。在较高的CsA浓度(≥50μM)下,外排和摄取活性的改变增强且变得不可逆,胆小管周围的F-肌动蛋白微丝紊乱,胆小管收缩。这些变化与内质网应激的诱导有关,内质网应激先于氧化应激的产生。在用CsA处理24小时后,观察到总胆汁酸处置存在浓度依赖性变化,其特征分别是培养基中增加而细胞内减少。因此,编码肝胆转运蛋白和胆汁酸合成酶的基因根据CsA浓度的不同而有不同程度的失调。相比之下,FK506仅在25 - 50μM时产生有限的影响,且不改变胆小管。我们的数据表明不同的浓度依赖性机制参与了CsA诱导的胆汁淤积,并指出内质网应激在主要胆汁淤积特征发生中的关键作用。